MDMustafa Deniz

Mustafa Deniz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mustafa Deniz has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cerebrospinal fluid lipocalin-2 and bactericidal/permeability-increasing protein in acute bacterial versus viral meningitis: a prospective study

    by Mustafa Deniz, Derya Seyman, Güzin Aykal

    Distinguishing acute bacterial meningitis (ABM) from acute viral meningitis (AVM) remains challenging in clinically ambiguous scenarios, particularly during early disease stages or following partial antibiotic treatment. This study aimed to evaluate the diagnostic accuracy of cerebrospinal fluid (CSF) lipocalin-2 (LCN-2) and Bactericidal/Permeability-Increasing Protein (BPI) for the rapid differentiation of ABM from AVM. In this prospective study (November 2020-October 2021), 90 adult patients were categorized into ABM, AVM, and control groups based on clinical and laboratory definitions. CSF LCN-2 and BPI levels were quantified using enzyme-linked immunosorbent assay (ELISA). Group comparisons were performed using Mann-Whitney U and Kruskal-Wallis tests. Diagnostic performance was evaluated using Receiver Operating Characteristic (ROC) curve analyses to determine sensitivity, specificity, and optimal cut-off values. Analysis of a cohort of 90 patients revealed that CSF LCN-2 levels were significantly higher in the ABM group (median: 103.2 ng/mL) compared to the AVM group (median: 99.3 ng/mL; p = 0.003) and controls (p < 0.001). Applying a threshold of greater than 100.7 ng/mL, LCN-2 differentiated ABM from AVM with a sensitivity of 83.3% and a specificity of 60.0%. In contrast, CSF BPI levels did not demonstrate significant diagnostic value (p > 0.05). CSF LCN-2 demonstrated high sensitivity as a biomarker for distinguishing ABM from AVM, indicating its potential as an adjunctive tool for early clinical decision-making. In contrast, BPI did not demonstrate adequate diagnostic utility in this cohort. Further multicenter studies with larger sample sizes are necessary to confirm the clinical applicability of LCN-2.

  • Open Access

    Point–Prevalence of Antimicrobial–Related Potential Drug–Drug Interactions in Hospitalized Older Adults: A Multicenter Study Using Lexicomp

    by Yusuf Arslan, Esra Gürbüz, Sevil Alkan, Servan Vurucu, Yeliz Çiçek, Yusuf Özkaraman, Mustafa Deniz, Zekiye Hakseven-Karaduman, Ali İrfan Baran, Mehmet Çelik, et al.

    Background/Objectives: Potential drug–drug interaction (pDDI) refers to the co–administration of two or more drugs that interact with each other and may have therapeutic effects. Increasing rates of polypharmacy with age increase the risk of pDDIs in geriatric patients. This multicenter study aims to provide real–world data on the incidence of pDDI associated with antimicrobial therapy in hospitalized older adults. Methods: The study screened all hospitalized patients, including those aged 65 years and older. Using the Lexicomp® Drug Interaction Online Database, researchers screened for pDDIs among all medications taken by patients. Results: 663 (24.0%) aged 65 and over were included in the study. Polypharmacy was present in 64.9%, and hyperpolypharmacy was present in 10.0% of the cases. 480 (72.4%) of the cases used antimicrobial therapy. The mean total number of drugs and antimicrobials used per case was 5.86 and 1.02, respectively. A total of 372 antimicrobial–related pDDIs were detected, and at least one antimicrobial–related pDDI was identified in 202 (42%) patients receiving antimicrobials. Ciprofloxacin (73.3%), clarithromycin (58.3%), and colistin (26.3%) had the highest numbers of D–type pDDIs. The antimicrobials with the highest incidence of X–type pDDIs were metronidazole (23.6%) and clarithromycin (8.3%), respectively. The logistic analysis found a significant association between antimicrobial–related pDDIs and an increase in the number of drugs, length of hospital stays, and ID departments. Conclusions: PDDI rates associated with antimicrobials, like the high pDDI rates associated with all drugs, support the literature. Therefore, strategies should be developed to reduce the risk of pDDI when prescribing antimicrobials to geriatric patients.


  • Open Access

    Predictors for Publication of Specialty Theses in the Field of Infectious Diseases and Clinical Microbiology

    by Pelin Irkören, Elif Aguloglu Bali, Oguz Usta, Arzu Senol, Baris Manavli, Busra Tanir, Esra Gurbuz, Halime Araz, Isıl Deniz Aliravci, Ilkay Nur Can, et al.

    The residency program of infectious diseases and clinical microbiology (IDCM) in Türkiye was started in 1983 by adopting the name IDCM. The IDCM program in Türkiye is a five-year program, including related clinical rotations. Presenting a thesis at the end of this program is mandatory. The first specialty thesis in the field of IDCM was


  • Open Access

    Infections Observed in Patients with Intravenous Drug Use

    by Zafer Adıguzel, Derya Seyman, Aysegul Seremet-Keskin, Mustafa Deniz, Yusuf Özkaraman

    Objective: In the last decade, intravenous drug use (IVDU)-associated infections have increased significantly in parallel with the increase in intravenous drug addiction. Skin and soft tissue infections (SSTIs) and infective endocarditis (IE) are the most common infections and are important causes of morbidity and mortality. We aimed to share our experience regarding the epidemiology, microbiology, diagnosis, and management of IVDU-associated infections. Methots: Patients hospitalized with IVDU-associated bacterial infections between January 2014 and December 2023 were included in this descriptive and retrospective study. Results: Seventy-three IVDU-associated infections were identified in 66 patients. The median age was 30.5±7.23 years, and 90.9% were male; 35 (47.9%) were SSTI, 29 (39.7%) IE, 3 (4.1%) pneumonia, and one patient each (1.3%) had acute hepatitis B and brain abscess. Four (5.4%) had both SSTI and IE. Chronic hepatitis C (83.3%) was the most common viral infection. 24.2% of them had deep vein thrombosis. The leg (33.3%) and forearm (20.5%) were the most frequently affected areas in SSTI, and 19 (48.7%) were abscesses, 14 (35.9%) cellulitis, 5 (12.8%) necrotizing SSTIs and one septic arthritis. Osteomyelitis was observed in 8 (20.5%) of the SSTIs. Half (51.2%) of the SSTI patients underwent surgical intervention. Blood cultures were taken from 82% (n=32) of 39 SSTIs, and bacteremia was detected in 37.5% (n=12). Microorganisms were identified in 84% (n=21) of 25 abscesses; four were polymicrobial. Of 33 IE patients, 84.8% had right-sided IE. The tricuspid valve (96.4%) was most commonly involved; septic pulmonary embolism was documented in 20 (71.4%) of the patients. Valve surgery was performed in nine of the patients (27.2%). Methicillin susceptible Staphylococcus aureus was the most common pathogen (35.7%), followed by methicillin-resistant S. aureus (22.8%). The mortality rate was 9%. Conclusion: Increase in IVDU is an urgent public problem for our country. Multidisciplinary approach and antimicrobial treatment are essential in the treatment of IVDU associated-SSTI and IE.


  • Open Access

    Clinical Entity Mimicking Infectious Cellulitis: Eosinophilic Cellulitis (Wells’ Syndrome)

    by Mustafa Deniz, Kübra Demir-Önder, Yusuf Özkaraman, Zafer Adıgüzel, Kadir Balaban

    Eosinophilic cellulitis (EC) is a rare inflammatory skin condition with fewer than 200 documented cases in the medical literature. There are only a limited number of case reports available from our country. The prevalence and incidence of EC are unknown. The disease is characterized by pruritic, non-purulent, erythematous plaques (...)


  • Open Access

    Vector-Borne Endemic Viral Infection in Antalya Region: Sandfly Fever

    by Yusuf Ozkaraman, Derya Seyman, Aysegul Seremet-Keskin, Mustafa Deniz, Zafer Adıguzel, Yusuf ÖzkaramanAffiliationsSağlık Bilimleri Üniversitesi Antalya Eğitim ve Araştırma Hastanesi, İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Antalya, Derya SeymanAffiliationsSağlık Bilimleri Üniversitesi Antalya Eğitim ve Araştırma Hastanesi, Ayşegül Seremet-KeskinAffiliationsSağlık Bilimleri Üniversitesi Antalya Eğitim ve Araştırma Hastanesi, et al.

    Objective: Sandfly fever (SF) is a self-limited vector-related viral infection caused by the SF virus and is spread by phlebotomine sandflies (PSF). Fever, headache, myalgia, arthralgia, loss of appetite, weakness, nausea, and vomiting are the most common symptoms. Laboratory findings include leukopenia, thrombocytopenia, and elevated liver trans-aminase enzymes. We aimed to examine the demographic, clinical, and laboratory data of patients who were followed with SF diagnosis.Methods: Patients who were followed with SF diagnosis in our hospital between January 2011 and December 2018 were included. The data were obtained retrospectively.Results: A total of 64 patients were included in the study. The mean age was 33.1 +/- 9.7(min:19-max:58) years and 35(54.7%) of them were male. Although 53.1% had a history of contact with PSF, 92.2% had a bite mark. 91.6% of the patients were living on the ground and first floor. Fever was the most common symptom in 95.3% of the patients; 89% had myalgia-weakness, 79.6% had a headache, and 50% had a conjunctival rash. Increased transaminase enzyme levels were observed in approximately 93% of the patients. The average of ALT and AST were 284.7 U/L and 243.5 U/L, re-spectively. Leukopenia was observed in 79.6% (51/64) of them, and thrombocytopenia in 78% (50/64). CK elevation was 54% ratio (35/64). Samples were tested from 19 patients for the serological diagnosis of SF. IgM was positive in 15 (78.9%) of 19 patients and negative in 4(21%) patients. IgG was positive in 10 (52.6%) of 19 patients. Both IgG and IgM were positive in 9 patients. Only IgG positivity was detected in one patient. Conclusion: SF should be considered in patients presenting with complaints such as fever, headache, muscle joint pain, nausea-vomiting, redness in the eyes, leukopenia, thrombocytopenia, elevated transaminase enzyme, CK level, and living in or having a history of travel to subtropical regions, especially during the summer season and a history of PSF contact.


  • The effect of intubation type and place of intubation on the development of ventilator-associated pneumonia

    by Kübra Demi̇r Önder, Ayşegül SEREMET KESKİN, Filiz Kizilateş, Mustafa Deni̇z

    Amaç: Çalışmamızda entübasyon türünün (elektif veya acil) ve entübasyonun yapıldığı ortamın, ventilatör ilişkili pnömoni (VİP) gelişimi üzerine etkisinin incelenmesi amaçlanmıştır. Yöntem: 1 Şubat 2019 ve 28 Şubat 2020 tarihleri arasında VİP tanısı almış, erişkin hastalar çalışmaya alındı. Yatış nedeni, entübasyon türü (elektif, acil), entübasyonun yapıldığı yer (ambulans, acil servis, yatan hasta servisi, yoğun bakım, ameliyathane), VİP gelişene kadar geçen süre ve mortalite durumları retrospektif olarak incelendi. Bulgular: Çalışmaya 180 VİP tanılı hasta dahil edildi. Hastaların %55’ ine acil entübasyon, %45’ ine elektif entübasyon yapıldığı saptandı. Entübasyon sonrası VİP gelişimine kadar geçen ortalama süre 7,9 ± 5,9 gündü. Acil entübasyonlarda VİP gelişimine kadar geçen süre elektif entübasyonlara göre daha kısa idi (sırasıyla 6.8± 4.58 vs 9.1± 7.09 gün, p=0.023). Hastaların %33.9’unun yoğun bakımda, %26.7’ sının acil serviste, %17.2’sinin ameliyat öncesinde, %11.7’sinin yatan hasta servisinde ve %10.6’sının hastaneye getirilmeden önce entübe edildiği görüldü. 7 gün mortalite %20, 14 gün mortalite %36.7, 30 gün mortalite %46.7 olarak saptandı. Kaba mortalite ve entübasyonun yapıldığı yer arasında istatiksel anlamlı ilişki saptanmadı (p=0.366). Acil entübasyon yapılan hastalarda VİP sonrası 7, 14 ve 30 gün mortalite oranlarının elektif entübasyona göre daha fazla olduğu saptandı. Sonuç: Acil entübasyonlarda elektiflere göre VİP gelişme süresinin daha kısa olduğu (p=0,009) ve tüm nedenlere bağlı mortalitenin istatistiksel anlamlı fark olmasa da acil entübasyon yapılanlarda elektif entübasyon yapılanlara göre daha fazla olduğu saptandı. Enfeksiyon kontrol önlemlerinin acil entübasyonlarda tam uygulanamamasının bu sonuca neden olduğu düşünüldü.

  • Open Access

    Healthcare personnel’s attitude and coverage about tetanus vaccination in Turkey: a multicenter study

    by Derya Seyman, Ayşegül Seremet Keskin, Emine Küçükateş, Mehmet Reşat Ceylan, Gülnur Kul, Selma Tosun, Ayşe Ferdane Oğuzöncül, Özlem Zanapalıoğlu Gazel, Hanife Uzar, Serhat Uysal, et al.

    The tetanus vaccine is not routinely given to Turkish adults. Protective tetanus immunity decreases with age. Health-care personnel (HCPs), who are role models in the field of health, are a target group in order to achieve a higher rate of tetanus vaccination in the community. This study was designed to evaluate attitudes and coverage regarding tetanus vaccination among a large sample of Turkish HCPs. This cross-sectional epidemiologic study was conducted from July to August 2019. A questionnaire was sent to HCPs using social media. Of the 10,644 HCPs included in the study, 65% were female. Overall, the tetanus vaccination coverage (TVC) among HCPs was 78.5% (95% CI: 77.7%-79.3%). TVC was significantly higher among physicians [83.4% (95% CI: 82%-84.6%); p < .001] compared with all other HCPs except nurses. Older age (≥40 years) and length of professional experience were significantly correlated with TVC. Of the 8353 HCPs who received tetanus vaccines during their lifetime, 73.03% received tetanus vaccination in the past 10 years. The self-vaccination rate for protection against tetanus was 13.1%. Acute injuries (25.42%) and pregnancy (23.9%) were the most common reasons for having the tetanus vaccine. One-third (33.7%) of HCPs did not have information about whether pregnant women could receive tetanus vaccinations. This survey study provided excellent baseline information about HCPs’ coverage rates and attitudes regarding tetanus vaccination. The present results suggested that tetanus boosters for HCPs should be established as soon as possible, and revealed that the HCPs younger than 30 years with relatively less professional experience and all other HCPs except nurses and physicians should be identified as the target population for future intervention programs.


  • Prevalence and Related Risk Factors of Non-Alcoholic Fatty Liver Disease In HIV/AIDS Patients

    by Figen Sarıgül, Mustafa Deniz

    Objective: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of fatty liver without inflammatory infiltration, excessive alcohol consumption, viral hepatitis, and other liver diseases. NAFLD is a major health problem as it can lead to cirrhosis, liver cancer and mortality. In HIV-positive patients, the prevalence of NAFLD ranges from 28 to 48%. Currently, there is no information about the prevalence and related factors related to NAFLD in those with HIV infection in our country. In this study, we aimed to investigate the prevalence of NAFLD and the related factors in newly diagnosed HIV-infected patients. Methods: The demographic data and ultrasonography of 558 HIV-infected patients newly diagnosed between June 2015 and September 2019 were analyzed retrospectively. In hepatic echogenicity, fatty liver was diagnosed with hyper echogenicity of liver compared with renal cortex and diffusion. Uni- and multi-variate logistic regression analyses were applied to estimate factors associated with NAFLD. Results: Of 358 patients who met the study criteria, 118 (33%) were diagnosed as NAFLD. Obesity was found in 10.2% of the patients with NAFLD and in 3.1% of the patients without NAFLD (p=0.021). NAFLD rate was significantly higher in patients with diabetes mellitus and hypertension (p<0.05). In the multivariate analysis, age, 1 mg/dl increase in glucose and triglyceride values and 1 unit increase in ALT/AST were associated with NAFLD. Conclusions: The results highlight the importance of early recognition and management of NAFLD and traditional factors associated with NAFLD in Turkish patients with HIV infection. Additionally, precautions and treatments should be a priority in the follow-up of patients in order to ensure the reduction of liver-related morbidity and mortality, which is one of the non-AIDS causes of these newly diagnosed HIV-infected patients.